Gothenburg, Sweden

Isidor Brajnovic

This inventor holds 1 USPTO granted patent. Top assignee: Nobelpharma Ab. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Isidor Brajnovic: Innovator in Dental Implant Technology

Introduction

Isidor Brajnovic is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of dental implant technology. His innovative approach has led to the development of a unique system that enhances the adaptability of dental implants.

Latest Patents

Brajnovic holds a patent for a system that is individually adaptable to elements implanted in the dentine. This bridge system is designed to be customized to elements implanted in dentine, joints, or similar parts. The system comprises at least two module units that can be attached to the implanted elements or parts. These units feature first surfaces for attachment and second surfaces that are separate from the first. An elongate, curved member is secured in the module units at the second surfaces. This member is made of titanium or a material with similar tissue affinity. Its design allows for bending without compromising strength, facilitating the secure attachment of prosthetic parts.

Career Highlights

Brajnovic is associated with Nobelpharma AB, a company known for its advancements in dental technology. His work has been instrumental in developing solutions that improve patient outcomes in dental procedures.

Collaborations

One of his notable collaborators is Stig Gosta Wennberg, with whom he has worked closely on various projects related to dental implants.

Conclusion

Isidor Brajnovic's contributions to dental implant technology exemplify innovation in the field. His patented system showcases his commitment to enhancing dental solutions for better patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…